Atherosclerotic disease has the potential to produce catastrophic medical events which could change a person’s life, and in some cases change a patient’s family life. Such events are typically strokes or heart attacks. Prevention is better than cure and currently appropriate medical or surgical therapy can reduce the number of such events by 50%.
Carotid endarterectomy combined with medical treatment is an established method of treating symptomatic patients with moderate to severe internal carotid artery stenosis. It reduces stroke by more than 50%. However the place of carotid erdarterectony in the treatment of asymptomatic patients remains controversial. This is because until recently stroke risk stratification was not possible in patients with asymptomatic carotid stenosis.
The technology LifeQ has developed helps calculate this risk and has the potential to identify the asymptomatic patients at high risk who need the operation and spare those at low risk from an unnecessary and expensive procedure which is not without it’s own risks.